Rating #87
Larry Robbins
Glenview Capital Management
Portfolio value
Stocks
Performance
1 Year
+21.66%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Larry Robbins’ Portfolio: Q4 2025
Top10 stocks: 60.46% of the portfolio
Larry Robbins’ Trades: Q4 2025
Adds
New Buys
Sold Outs
Cuts
-0.18ppt
1.08ppt
1.26ppt
0.61ppt
0.99ppt
0.80ppt
0.36ppt
-0.01ppt
0.15ppt
0.55ppt
Company Name | Share Count Chg. (%) | Price Paid | Buy Value | Portfolio % Change | |
|---|---|---|---|---|---|
1  GPN | Add +15.15% | $80.49 | $62.72M | -0.18ppt | |
2  AMZN | Add +39.43% | $228.79 | $58.83M | 1.08ppt | |
3  CNC | Add +398.93% | $37.43 | $55.54M | 1.26ppt | |
4  XYZ | Add +164.18% | $68.98 | $36.50M | 0.61ppt | |
5  VTRS | Add +34.43% | $10.79 | $30.64M | 0.99ppt | |
6  KNX | Add +69.67% | $46.87 | $28.08M | 0.80ppt | |
7  CI | Add +48.79% | $280.35 | $25.68M | 0.36ppt | |
8  SGRY | Add +51.49% | $18.38 | $24.10M | -0.01ppt | |
9  UBER | Add +50.00% | $90.05 | $21.24M | 0.15ppt | |
10  ONTO | Add +53.29% | $142.02 | $20.48M | 0.55ppt |
Larry Robbins’ Holdings: Q4 2025
Company Name | Primary Industry | Avg. price paid  | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1  CVS | Retail-Drug Stores | $62.26 | 0.00% | 8.20M | $650.50M | 13.24% -0.52ppt | 0.65% | 9 Quarters | Q2 2025 | |
2  TEVA | Pharmaceutical Pres | $14.91 | Add +0.16% | 16.72M | $521.84M | 10.62% 3.11ppt | 1.46% | 9 Quarters | Q4 2025 | |
3 GPN | Other Business Services | $111.21 | Add +15.15% | 5.92M | $458.29M | 9.33% -0.18ppt | 2.47% | 21 Quarters | Q4 2025 | |
4  THC | Other General Medical Hospitals | $63.97 | Cut -14.63% | 1.98M | $394.21M | 8.02% -2.48ppt | 2.18% | 53 Quarters | Q4 2025 | |
5 AMZN | Retail-Catalog & Mail-Order | $190.88 | Add +39.43% | 909.27K | $209.88M | 4.27% 1.08ppt | 0.01% | 21 Quarters | Q4 2025 | |
6  GTM | Interactive Media and Services | $5.13 | Add +8.11% | 20.01M | $203.45M | 4.14% -0.35ppt | 0.00% | 7 Quarters | Q4 2025 | |
- | $80.63 | New Buy +100.00% | 1.77M | $142.95M | 2.91% 2.91ppt | - | 1 Quarter | Q4 2025 | ||
8 VTRS | Pharmaceutical Pres | $11.51 | Add +34.43% | 11.09M | $138.04M | 2.81% 0.99ppt | 0.95% | 9 Quarters | Q4 2025 | |
9  TMO | Other Measuring Devices | $456.90 | Cut -20.85% | 223.95K | $129.77M | 2.64% -0.41ppt | 0.06% | 3 Quarters | Q4 2025 | |
10  DXC | Data Processing Services | $27.91 | Cut -0.28% | 8.32M | $121.83M | 2.48% -0.05ppt | 4.69% | 35 Quarters | Q4 2025 | |
11  DOCN | Computer Programming & Data | $48.12 | New Buy +100.00% | 2.00M | $96.45M | 1.96% 1.96ppt | 2.19% | 1 Quarter | Q4 2025 | |
12  EXPE | Transportation Services | $120.03 | Cut -10.61% | 321.63K | $91.12M | 1.85% 0.14ppt | 0.26% | 14 Quarters | Q4 2025 | |
13  USFD | Wholesale-Groceries | $46.12 | Add +6.80% | 1.14M | $85.70M | 1.74% -0.07ppt | 0.51% | 17 Quarters | Q4 2025 | |
14  AMD | Semiconductors | $214.16 | New Buy +100.00% | 394.19K | $84.42M | 1.72% 1.72ppt | 0.02% | 1 Quarter | Q4 2025 | |
15  Z | Other Business Services | $74.97 | Add +30.79% | 1.16M | $79.38M | 1.62% 0.09ppt | 0.48% | 2 Quarters | Q4 2025 | |
16 CI | Medical Service Plans | $257.19 | Add +48.79% | 279.37K | $76.89M | 1.56% 0.36ppt | 0.11% | 29 Quarters | Q4 2025 | |
17 CNC | Medical Service Plans | $40.05 | Add +398.93% | 1.86M | $76.37M | 1.55% 1.26ppt | 0.38% | 7 Quarters | Q4 2025 | |
18 KNX | Non-Local Trucking | $51.46 | Add +69.67% | 1.46M | $76.27M | 1.55% 0.80ppt | 0.90% | 12 Quarters | Q4 2025 | |
19  ESI | Other Chemical Products | $22.60 | Add +28.39% | 2.83M | $70.82M | 1.44% 0.20ppt | 1.17% | 28 Quarters | Q4 2025 | |
20  LION | Blank Checks | $7.64 | Add +50.14% | 7.51M | $68.54M | 1.39% 0.63ppt | 2.59% | 2 Quarters | Q4 2025 |
NEWSLETTER
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersOur content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.